Competitive AMPA antagonism: a novel mechanism for antiepileptic drugs?

被引：20

作者：

Auberson, YP ^{[1
]}

机构：

[1] Novartis Pharma AG, Nervous Syst Res, CH-4002 Basel, Switzerland

来源：

DRUGS OF THE FUTURE | 2001年 / 26卷 / 05期

关键词：

D O I：

10.1358/dof.2001.026.05.659545

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

[No abstract available]

引用

页码：463 / 471

页数：9

共 90 条

[51] 6-(1H-imidazol-1-yl)-7-nitro-2,3(1H,4H)-quinoxalinedione (YM90K) and related compounds: Structure-activity relationships for the AMPA-type non-NMDA receptor (vol 37, pg 471, 1994) [J].

Ohmori, J ;

Sakamoto, S ;

Kubota, H ;

ShimizuSasamata, M ;

Okada, M ;

Kawasaki, S ;

Hidaka, K ;

Togami, J ;

Furuya, T ;

Murase, K .

JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (05) :826-826

[52] 6-(1H-IMIDAZOL-1-YL)-7-NITRO-2,3(1H,4H)-QUINOXALINEDIONE HYDROCHLORIDE (YM90K) AND RELATED-COMPOUNDS - STRUCTURE-ACTIVITY-RELATIONSHIPS FOR THE AMPA-TYPE NON-NMDA RECEPTOR [J].

OHMORI, J ;

SAKAMOTO, S ;

KUBOTA, H ;

SHIMIZUSASAMATA, M ;

OKADA, M ;

KAWASAKI, S ;

HIDAKA, K ;

TOGAMI, J ;

FURUYA, T ;

MURASE, K .

JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (04) :467-475

[53] VALPROATE ENHANCES GABA-A MEDIATED INHIBITION OF LOCUS COERULEUS NEURONS INVITRO [J].

OLPE, HR ;

STEINMANN, MW ;

POZZA, MF ;

BRUGGER, F ;

SCHMUTZ, M .

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1988, 338 (06) :655-657

[54] (3SR,4ARS,6RS,8ARS)-6-[2-(1H-TETRAZOL-5-YL)ETHYL]DECAHYDROISOQUINOLINE-3-CARBOXYLIC ACID - A STRUCTURALLY NOVEL, SYSTEMICALLY ACTIVE, COMPETITIVE AMPA RECEPTOR ANTAGONIST [J].

ORNSTEIN, PL ;

ARNOLD, MB ;

AUGENSTEIN, NK ;

LODGE, D ;

LEANDER, JD ;

SCHOEPP, DD .

JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (14) :2046-2048

[55]

Peeters B.W.M.M., 1988, NEUROSCI RES COMMUN, V2, P93

[56] THE WAG/RIJ RAT MODEL FOR NONCONVULSIVE ABSENCE EPILEPSY - INVOLVEMENT OF NONNMDA RECEPTORS [J].

PEETERS, BWMM ;

RAMAKERS, GMJ ;

VOSSEN, JMH ;

COENEN, AML .

BRAIN RESEARCH BULLETIN, 1994, 33 (06) :709-713

[57] LU 73068, a new non-NMDA and glycine/NMDA receptor antagonist:: pharmacological characterization and comparison with NBQX and L-701,324 in the kindling model of epilepsy [J].

Potschka, H ;

Löscher, W ;

Wlaz, P ;

Behl, B ;

Hofmann, HP ;

Treiber, HJ ;

Szabo, L .

BRITISH JOURNAL OF PHARMACOLOGY, 1998, 125 (06) :1258-1266

[58] Synthesis and potent anticonvulsant activities of 4-oxo-imidazo[1,2-a]indeno[1,2-e]pyrazin-8-and-9-carboxylic (acetic) acid AMPA antagonists [J].

Pratt, J ;

Jimonet, P ;

Bohme, GA ;

Boireau, A ;

Damour, D ;

Debono, MW ;

Genevois-Borella, A ;

Randle, JCR ;

Ribeill, Y ;

Stutzmann, JM ;

Vuilhorgne, M ;

Mignani, S .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (24) :2749-2754

[59] NEUROBIOLOGY OF SEIZURE PREDISPOSITION .1. THE GENETICALLY EPILEPSY-PRONE RAT - AN OVERVIEW OF SEIZURE-PRONE CHARACTERISTICS AND RESPONSIVENESS TO ANTICONVULSANT DRUGS [J].

REIGEL, CE ;

DAILEY, JW ;

JOBE, PC .

LIFE SCIENCES, 1986, 39 (09) :763-774

[60]

Renier WO, 2000, NEUROSCI RES COMMUN, V26, P181, DOI 10.1002/1520-6769(200005/06)26:3<181::AID-NRC6>3.0.CO

← 1 2 3 4 5 6 7 8 9 →